Results 231 to 240 of about 168,862 (349)

Artificial intelligence for risk assessment and outcome prediction in malignant haematology

British Journal of Haematology, EarlyView.
Machine learning models allow for dynamic and scalable risk stratification and outcome prediction. Different modalities of data such as electronic health records, patient genetics or laboratory results can be used as input. ML models autonomously select features weighing their prognostic value. Methods of model explainability in feature selection allow
Jan‐Niklas Eckardt, Wencke Walter, Jan Moritz Middeke, Torsten Haferlach   +3 more
wiley   +1 more source

MLR Corresponds to the Functional Status of Monocytes in Chronic Lymphocytic Leukemia. [PDF]

Int J Inflam
Grzegorzewska W, Zarobkiewicz M, Jastrzębska-Pawłowska K, Lehman N, Tomczak W, Mizerska-Kowalska M, Bojarska-Junak A, Roliński J.   +7 more
europepmc   +1 more source

Chronic Lymphocytic Leukemia (CLL): First-Line Treatment [PDF]

, 2005
Michael Hallek
openalex   +1 more source

The Role of Tumor Microenvironment and Targeted Therapy in Chronic Lymphocytic Leukemia. [PDF]

Curr Issues Mol Biol
Saleh K, Arbab A, Khalife N, Khoury R, Ibrahim R, Hachem MA, Khalil C, Bou Orm C, Sawan J, Lafarge G, Masri N, Tikriti Z, Chahine C, Le Cesne A.   +13 more
europepmc   +1 more source

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: Extended phase 3 results from RESONATE-2 [PDF]

, 2018
Bartlett, Nancy L, et al.,
core   +1 more source

Correction for: Accelerated chronic lymphocytic leukemia - characteristics and retrospective analysis of the Polish Adult Leukemia Study Group. [PDF]

Contemp Oncol (Pozn)
Sośnia O, Iskierka-Jażdżewska E, Puła A, Wiśniewski K, Drozd-Sokołowska J, Morawska M, Gosik U, Woszczyk D, Ogłoza A, Wdowiak K, Paszkiewicz-Kozik E, Wąsik-Szczepanek E, Markiewicz M, Zawartko M, Kokoć A, Szumera-Ciećkiewicz A, Prochorec-Sobieszek M, Jesionek-Kupnicka D, Braun M, Gierej B, Robak T, Lech-Marańda E, Puła B.   +22 more
europepmc   +1 more source

Prognostic significance of in patients with chronic lymphocytic leukemia: A meta-analysis. [PDF]

Ann Hematol
Huang L, Shi X, Tang N, Liu J, Liang Y, Wang X.   +5 more
europepmc   +1 more source

IGHV1 usage is associated with lymphadenopathy and aggressive disease in the TCL1 mouse model for chronic lymphocytic leukemia. [PDF]

Sci Rep
Drothler S, Scherhäufl C, Suete C, Parigger T, Gassner FJ, Pleyer L, Egle A, Greil R, Geisberger R, Zaborsky N.   +9 more
europepmc   +1 more source

Editorial: Reviews in hematologic malignancies: 2023

Frontiers in Oncology
Billy Michael Chelliah Jebaraj, Michael Liew, Felix Seyfried   +2 more
doaj   +1 more source

V-H gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia [PDF]

, 2003
Amlot, P, Duke, VM, Foroni, L, Gandini, D, Heelan, B, Hoffbrand, AV, Lin, K, Mehta, AB, Sherrington, PD   +8 more
core